期刊文献+

缺血性脑卒中溶栓院内延迟影响因素研究 被引量:2

下载PDF
导出
摘要 目的:探讨缺血性脑卒中溶栓院内延迟的影响因素。方法:选取本院2016-04~2018-04收治98例血性脑卒中患者按照发病至溶栓时间分组,将发病至溶栓时在3~4.5h作为延迟组,将发病至溶栓时间3h内作为非延迟组,采用多因素Logisitic回归分析缺血性脑卒中溶栓院内延迟影响因素。结果:延迟组NIHSS评分≥10分、CT检查时间≥20min、获取CT报告时间≥30min、溶栓组医师会诊时间≥20min的比例均高于非延迟组(P<0.05),多因素Logistic回归分析显示NIHSS评分、CT检查时间、获取CT报告时间、溶栓组医师会诊时间是缺血性脑卒中溶栓院内延迟的独立影响因素。结论:影响缺血性脑卒中患者溶栓院内延迟的主要原因是NIHSS评分≥4分、CT检查时间≥20min、获取CT报告时间≥30min、溶栓组医师会诊时间≥20min。
出处 《黑龙江医药科学》 2019年第4期131-132,共2页 Heilongjiang Medicine and Pharmacy
  • 相关文献

参考文献6

二级参考文献44

  • 1黄小钦,贾建平,刘丽旭,马欣.早期就诊的急性缺血性卒中病人未溶栓原因分析[J].脑与神经疾病杂志,2007,15(5):346-348. 被引量:15
  • 2Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention ; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Nenrology affirms the value of this statement as an educational tool for neurologists[ J]. Stroke, 2009, 40(6) : 2276-2293.
  • 3短暂性脑缺血发作中国专家共识组.短暂性脑缺血发作的中国专家共识更新版(2011)[J].中华危重症医学杂志(电子版),2012,5(2):100-105.
  • 4Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes [ J ]. Circulation, 2011, 123 ( 7 ) : 750-758.
  • 5Wang Y, Liao X, Zhao X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR) [ J ]. Stroke, 2011, 42 ( 6 ) : 1658-1664.
  • 6Fonar'ow GC, Reeves M J, Smith EE, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guiddines-stroke[ J ]. Circ Cardiovasc Qual Outcomes, 2010, 3 (3) :291-302.
  • 7Eissa A, Krass I, Levi C, et al. Understanding the reasons behind the low utilisation of thrombolysis in stroke [ J ]. Australas Med J, 2013, 6 (3) : 152-167.
  • 8Fonarow GC, Smith EE, Saver JL, et al. Improving door-to- needle times in acute ischemic stroke:the design and rationale for the American Heart Association/American Stroke Association's Target :Stroke initiative [ J ]. Stroke, 2011, 42 ( 10 ) : 2983-2989.
  • 9Smith EE, Fonarow GC, Reeves M J, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke[ J]. Stroke, 2011 , 42 ( 11 ) : 3110-3115.
  • 10Leira EC, Ludwig BR, Gurol ME, et al. The types of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores [ J ]. Stroke,2012, 43 ( 3 ) : 782-786.

共引文献33156

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部